| Name | Title | Contact Details |
|---|---|---|
Timothy Jones |
Chief Technical Officer | Profile |
MicroSurgical Technology is a Redmond, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NexGen Healthcare is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AmeriChoice of New York is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sarah Bush Lincoln Health Center is a 129-bed, not-for-profit, regional hospital centrally located in East Central Illinois Coles County, and is the recipient of the 2011 Illinois Performance Excellence Gold Award for Achievement of Excellence, the highest performance honors in the state. Sarah Bush Lincoln is accredited by The Joint Commission, the nations oldest and largest standards-setting and accrediting body in healthcare. The Health Center provides a full range of acute care services to residents of Coles County and the surrounding eight counties. Home health services extend to the surroundings 19 counties in East Central and Southern Illinois. Active and consulting medical staffs include approximately 175 providers representing 28 specialties. Some of the services provided by the Health Center include: a Regional Cancer Center, a Heart Center with Cardiac Catheterization and Rehabilitation in partnership with Prairie Heart Institute of Illinois, a Surgery Center, Women & Childrens Services, a Level II Perinatal Unit, Medical-Surgical units, Behavioral Health Services, Close Observation Unit, a Sleep Disorders Center, Diagnostic Imaging Services, and Laboratory. Outreach services include a durable medical company (Lincolnland Home Medical Equipment), a Reference Laboratory, Peace Meal, Lincolnland Home Health and Hospice, Lifeline, and Lincolnland Homemakers. Sarah Bush Lincoln has 14 extended campus primary care locations and three walk-in clinics. Employing about 2,350 area residents, the Health Center promotes a culture of excellence through continuing personal and professional growth.
Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.